Status | Study |
Recruiting |
Study Name: Early Vitrectomy for Macular Tractional Maculopathy Condition: Myopia, Degenerative Date: 2010-04-30 Interventions: Procedure: Early vitrectomy Triamcinolone acetonide assisted pars plana vitrectomy with Indocyanine gree |
Completed |
Study Name: Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen Condition: Choroidal Neovascularisation Date: 2009-12-21 Interventions: Drug: ranibizumab 0.5mg |
Completed |
Study Name: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy Condition: Coats' Disease Idiopathic Retinal Telangiectasia Retinal A Date: 2007-05-04 Interventions: Drug: ranibizumab injection (0.5 mg) ranibizumab 10mg mg/ml. , 0.3ml/vial, 0.05 ml./injection intravitre |
Completed |
Study Name: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) Condition: Choroidal Neovascularization Degenerative Myopia Date: 2006-12-01 Interventions: Drug: Bevacizumab |
Recruiting |
Study Name: Genomewide Screening of Pathological Myopia Condition: Pathological Myopia Date: 2005-09-09 |